
Dr. Fabian Falkenbach
@ffmed
Urologist @MartiniKlinik , Research Fellow @crchum
ID: 103137138
09-01-2010 01:07:45
2,2K Tweet
452 Followers
2,2K Following

🚨Aiming High: PSMA Expression in Treatment-naïve #prostatecancer 👏Martin Bakht & Misha Beltran provide editorial comments on our latest publication in European Urology "Given that PSMA PET scans are now routinely performed in newly diagnosed patients, this study is increasingly



Cutting Edge Communication: Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials by Daniel E Spratt et al Read the full article here:


Exciting developments in PSMA-targeted therapies for #ProstateCancer! This review explores the challenges of PSMA heterogeneity and the potential of combination therapies to enhance treatment outcomes. #ReadNow on UroToday > bit.ly/3AFgdWd Misha Beltran Jean-Philippe Theurillat


♊️ #DigitalTwins are paving the way for customized surgical planning and oncological pathways in #urology. Daniele Amparore pas_rescigno European Urology Oncology 👀 Is this already becoming a reality?" 👉 kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…


Most viewed in the last 7 days from JAMA Oncology: Is diet associated with risk of prostate cancer grade reclassification in men diagnosed with grade group 1 disease undergoing active surveillance? ja.ma/4fl1XB1


🚨MicroUS 🚨#OPTIMUM RCT for prostate cancer detection - 👏🏾 for completing trial. Eagerly awaiting results Hannes Cash leaving us in suspense - need to wait for #EAU25. Was hoping for 🎅to come early 😉 #EMUC24 European Association of Urology (EAU) European Society of Residents in Urology



🚨Overtreatment of #ProstateCancer Among Men With Limited Longevity🚨 👉Just out in JAMA Internal Medicine 🧑🧔♂️👴>240k pts w/ localized PCa from the VA (2000-2019) 📈Increased use of surveillance for low-risk tumors😃 BUT ALSO 📈Increased definitive treatment (surgery or XRT) for



Imaging and Focal Therapy of Early Prostate Cancer | A contribution from Focal Therapy Society for further development of #FocalTherapy Endourological Society Amer. Urol. Assn. European Association of Urology (EAU) SIU-Urology Confederación Americana de Urología (CAU) #MovingForward link.springer.com/book/10.1007/9…


Conventional imaging understages high-risk nonmetastatic prostate cancer. ☢️PSMA-PET was positive in 84% of cases, detecting M1 disease in 46%, polymetastatic in 24%. #ProstateCancer #PSMAPET #Oncology OncoAlert JAMA Network Open Advanced Prostate Cancer Consensus Conference



Impact of intraprostatic PSMA SUVmax following prostatectomy: a systematic review and meta-analysis First publication of 2025 - congrats David Chen marlon perera BJU International doi.org/10.1111/bju.16… "Preoperative intraprostatic PSMA SUVmax increases monotonically with higher ISUP




Happy to share our work publish at NEJM !! This achievement represents a significant step forward in transplantation. Proud to be part of this! Mass General Surgery Mass General Transplant Leonardo V. Riella nejm.org/doi/full/10.10…


PCa: Patient-reported Outcome Measures and Decision Regret After Prostate-specific Membrane Antigen–targeted Radioguided Surgery for Oligorecurrent Prostate Cancer by Dr. Fabian Falkenbach et al Full article: buff.ly/3EqnUS0 #UroSoMe #MedTwitter #PCa #ProstateCancer #euros


Ab#22 ASCO #GU25 by Dr. Tamim Niazi👉bit.ly/4hMu4KE👉Randomized ph2 study of MDT in oligometastatic CRPC #prostatecancer👉addition of SBRT to SOC doubled the median rPFS (& delayed time to next Rx)👇#ScottTyldesley OncoAlert UroToday.com PCF Science
